Abstract
In this study, a series of new indazole derivatives has been designed, synthesized and evaluated for inhibitory activity against anti-apoptotic Bcl-2 proteins (Bcl-2, Mcl-1, Bcl-xL). Among them, three products have demonstrated high inhibitory activity against Bcl-2/Mcl-1, which is similar to that of the positive control compound WL-276. Their poor Bcl-xL inhibitory activity allows to avoid platelet toxicity caused by Bcl-xL inhibition. Hence, they might be considered as lead compounds for developing Bcl-2/Mcl-1 dual inhibitors of higher potency.
Similar content being viewed by others
REFERENCES
Wan, Y.C., Dai, N.N., Tang, Z.L., and Fang, H., Eur. J. Med. Chem., 2018, vol. 146, p. 471. https://doi.org/10.1016/j.ejmech.2018.01.076
Roberts, A.W., Davids, M.S., Pagel, J.M., Kahl, B.S., Puvvada, S.D., Gerecitano, J.F., Kipps, T.J., Anderson, M.A., Brown, J.R., Gressick, L., Wong, S., Dunbar, M., Zhu, M., Desai, M.B., Cerri, E., Heitner Enschede, S., Humerickhouse, R.A., Wierda, W.G., and Seymour, J.F., N. Engl. J. Med., 2016, vol. 374, p. 311. https://doi.org/10.1056/NEJMoa1513257
Wang, L.Y., Sloper, D.T., Addo, S.N., Tian, D., Slaton, J.W., and Xing, C.G., Cancer Res., 2008, vol. 68, p. 4377. https://doi.org/10.1158/0008-5472.CAN-07-6590
Wan, Y.C., Wu, S.L., Xiao, G.Z., Liu, T.T., Hou, X.B., Chen, C.C., Guan, P., Yang, X.Y., and Fang, H., Bioorg. Med. Chem., 2015, vol. 23, p. 1994. https://doi.org/10.1016/j.bmc.2015.03.024
Mendgen, T., Steuer, C., and Klein, C.D., J. Med. Chem., 2012, vol. 55, p. 743. https://doi.org/10.1021/jm201243p
Wan, Y.C.; He, S.Z.; Li, W., and Tang, Z.L., Anticancer Agents Med. Chem., 2018, vol. 18, p. 1228. https://doi.org/10.2174/1871520618666180510113822
Wan, Y.C., Li, Y.H., Yan, C.X., Wen, J.J., and Tang, Z.L, Bioorg. Chem., 2020, vol. 104, p. 104217. https://doi.org/10.1016/j.bioorg.2020.104217
Wan, Y.C., Wang, J.H., Sun, F.E., Chen, M.L., Hou, X.B. and Fang, H., Bioorg. Med. Chem., 2015, vol. 23, p. 7685. https://doi.org/10.1016/j.bmc.2015.11.014
Liu, R.S., Liu, L.L., Liu, T.T., Yang, X.Y., Wan, Y.C., and Fang, H., Bioorg. Med. Chem., 2018, vol. 26, p. 4907. https://doi.org/10.1016/j.bmc.2018.08.030
Funding
This work was supported by National Natural Science Foundation of China (Grant no. 82003602, 21877034), The science and technology innovation Program of Hunan Province (Grant no. 2021RC5028), Scientific Research Fund of Hunan Provincial Education Department (Grant no. 21B0478) , Student Research and Innovation Program of Hunan University of Science and Technology (Grant no. YZ2141), and Open Project Program of Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education (Grant no. LKF202105).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors.
Rights and permissions
About this article
Cite this article
Luo, X., Deng, X., Ruan, J. et al. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors. Russ J Gen Chem 92, 1109–1114 (2022). https://doi.org/10.1134/S1070363222060238
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363222060238